In 2023, Russia registered 56 generic drugs specifically designed to treat cardiovascular diseases, along with 206 essential medical devices for individuals suffering from these conditions. The Deputy Minister of Health of the Russian Federation, Sergei Glagolev, presented this data during a meeting of the State Duma Committee on Health Protection.
Among the registered medical devices, the majority are pacemakers (36), as well as stents (24). Glagolev emphasized that, despite the difficult foreign economic conditions, the Russian pharmaceutical industry is actively working on import substitution and the creation of new drugs. This is facilitated, according to him, by government measures aimed at accelerating the registration of medical devices and drugs that are at risk of shortage.
